Sapio Sciences launches partner program to accelerate research and diagnostics

FHS
July 17, 2024
5:29 am

Sapio Sciences, the science-aware™ lab informatics platform, today announced the Sapio Partner Program.

J&J details Phase 3 success of autoimmune disease drug, touting broader range than argenx’s Vyvgart

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

June 29, 2024

Eli Lilly CEO says the company sees ‘significant common cause’ with Trump administration

SAN FRANCISCO — Eli Lilly CEO Dave Ricks on Tuesday said he believed the company could find “significant common cause” with the incoming Trump administration,

January 14, 2025

Pfizer details results from failed Phase 3 trial of Duchenne muscular dystrophy gene therapy

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

October 15, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.